Rapid initiation of antiretroviral therapy for people living with HIV
Referencias
Additional references
Abay SM, Deribe K, Reda AA, Biadgilign S, Datiko D, Assefa T, et al. The effect of early initiation of antiretroviral therapy in TB/HIV‐coinfected patients: a systematic review and meta‐analysis. Journal of the International Association of Providers of AIDS Care 2015;14(6):560‐70.
Adakun SA, Siedner MJ, Muzoora C, Haberer JE, Tsai AC, Hunt PW, et al. Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. Journal of Acquired Immune Deficiency Syndromes 2013;62(3):317‐21.
AIDSinfo. Guidelines for the use of antiretroviral agents in HIV‐1‐infected adults and adolescents. www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. U.S. Department of Health and Human Services, (accessed 28 June 2017).
AIDS Info. Immune Reconstitution Inflammatory Syndrome (IRIS). www.aidsinfo.nih.gov/understanding‐hiv‐aids/glossary/787/immune‐reconstitution‐inflammatory‐syndrome. U.S. Department of Health and Human Services, (accessed 28 June 2017).
Attawell K, Mundy J. Provision of antiretroviral therapy in resource‐limited settings: a review of experience up to August 2003. www.who.int/3by5/publications/documents/en/ARTpaper_DFID_WHO.pdf (accessed 24 June 2017).
Bassett IV, Regan S, Chetty S, Giddy J, Uhler LM, Holst H, et al. Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should. AIDS 2010;24(Suppl 1):S37‐44.
Black S, Zulliger R, Myer L, Marcus R, Jeneker S, Taliep R, et al. Safety, feasibility and efficacy of a rapid ART initiation in pregnancy pilot programme in Cape Town, South Africa. South African Medical Journal 2013;103(8):557‐62.
Black S, Zulliger R, Marcus R, Mark D, Myer L, Bekker LG. Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa. AIDS Care ‐ Psychological and Socio‐Medical Aspects of AIDS/HIV 2014;26(6):736‐41.
Bolsewicz K, Debattista J, Vallely A, Whittaker A, Fitzgerald L. Factors associated with antiretroviral treatment uptake and adherence: a review. Perspectives from Australia, Canada, and the United Kingdom. AIDS Care ‐ Psychological and Socio‐Medical Aspects of AIDS/HIV 2015;27(12):1429‐38.
Chan AK, Kanike E, Bedell R, Mayuni I, Manyera R, Mlotha W, et al. Same day HIV diagnosis and antiretroviral therapy initiation affects retention in Option B+ prevention of mother‐to‐child transmission services at antenatal care in Zomba District, Malawi. Journal of the International AIDS Society 2016;19(1):20672.
Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, Zhou J, Cesar C, et al. Universal definition of loss to follow‐up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Medicine 2011;8(10):e1001111.
Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, et al. Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. Journal of Acquired Immune Deficiency Syndromes 2013;62(2):e39‐46.
Cochrane Methods. Assessing risk of bias in included studies. methods.cochrane.org/bias/assessing‐risk‐bias‐included‐studies (accessed 14 July 2017).
Cochrane Training. Data collection forms for intervention reviews. training.cochrane.org/resource/data‐collection‐forms‐intervention‐reviews. The Cochrane Collaboration, (accessed 19 June 2017).
European AIDS Clinical Society. Guidelines Version 9.0. www.eacsociety.org/files/guidelines_9.0‐english.pdf. EACS, (accessed 24 January 2018).
Eshleman SH, Wilson EA, Zhang XC, Ou SS, Piwowar‐Manning E, Eron JJ, et al. Virologic outcomes in early antiretroviral treatment: HPTN 052. HIV Clinical Trials 2017;18(3):100‐9.
Fairall LR, Bachmann MO, Louwagie GMC, Van Vuuren C, Chikobvu P, Steyn D, et al. Effectiveness of antiretroviral treatment in a South African program: A cohort study. Archives of Internal Medicine 2008;168(1):86‐93.
Ford N, Migone C, Calmy A, Kerschberger B, Kanters S, Nsanzimana S, et al. Benefits and risks of rapid initiation of antiretroviral therapy. AIDS 2018;32(1):17‐23.
Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test‐and‐treat strategies for prevention of HIV infection. Clinical Infectious Diseases 2011;52(6):793‐800.
Govindasamy D, Ford N, Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. AIDS 2012;26(16):2059‐67.
Govindasamy D, Meghij J, Kebede Negussi E, Clare Baggaley R, Ford N, Kranzer K. Interventions to improve or facilitate linkage to or retention in pre‐ART (HIV) care and initiation of ART in low‐ and middle‐income settings ‐ a systematic review. Journal of the International AIDS Society 2014;17(1):19032.
Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ 2004;328(7454):1490.
GRADE Working Group, McMaster University. GRADEpro GDT. Version (accessed 19 January 2018). Hamilton (ON): GRADE Working Group, McMaster University, 2015.
Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, et al. Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV‐1 infection: results from the phase 3 HPTN 052 randomised controlled trial. Lancet. Infectious Diseases 2014;14(4):281‐90.
Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, et al. Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa. New England Journal of Medicine 2017;377(3):233‐45.
Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
HIV Modelling Consortium. Priorities for HIV care in sub‐Saharan Africa: a population perspective. www.hivmodelling.org/sites/default/files/uploads/documents/meeting‐reports/WSI%20HIVMC%20GRC%20report_2015‐09‐29.pdf (accessed 22 May 2015).
Hoehn N, Gill MJ, Krentz HB. Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care. AIDS Care 2017;29(5):564‐9.
Hoenigl M, Chaillon A, Moore DJ, Morris SR, Mehta SR, Gianella S, et al. Rapid HIV viral load suppression in those initiating antiretroviral therapy at first visit after HIV diagnosis. Scientific Reports 2016;6:32947.
Hønge BL, Jespersen S, Nordentoft PB, Medina C, da Silva D, da Silva ZJ, et al. Loss to follow‐up occurs at all stages in the diagnostic and follow‐up period among HIV‐infected patients in Guinea‐Bissau: a 7‐year retrospective cohort study. BMJ Open 2013;3(10):e003499.
Katirayi L, Namadingo H, Phiri M, Bobrow EA, Ahimbisibwe A, Berhan AY, et al. HIV‐positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study. Journal of the International AIDS Society 2016;19(1):20919.
Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub‐Saharan Africa: a systematic review. Journal of the International AIDS Society 2012;15(2):17383.
Labhardt ND, Ringera I, Lejone TI, Masethothi P, Thaanyane T, Kamele M, et al. Same day ART initiation versus clinic‐based pre‐ART assessment and counselling for individuals newly tested HIV‐positive during community‐based HIV testing in rural Lesotho ‐ a randomized controlled trial (CASCADE trial). BMC Public Health 2016;16:329.
Lawn SD, Myer L, Harling G, Orrell C, Bekker L‐G, Wood R. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clinical Infectious Diseases 2006;43(6):770‐6.
Lesko CR, Cole SR, Hall HI, Westreich D, Miller WC, Eron JJ, et al. The effect of antiretroviral therapy on all‐cause mortality, generalized to persons diagnosed with HIV in the USA, 2009‐11. International Journal of Epidemiology 2016;45(1):140‐50.
Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, et al. The "ART" of linkage: pre‐treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS ONE 2010;5(3):e9538.
MacCarthy S, Hoffmann M, Ferguson L, Nunn A, Irvin R, Bangsberg D, et al. The HIV care cascade: models, measures and moving forward. Journal of the International AIDS Society 2015;18(1):19395.
Mbonye M, Seeley J, Nalugya R, Kiwanuka T, Bagiire D, Mugyenyi M, et al. Test and treat: the early experiences in a clinic serving women at high risk of HIV infection in Kampala. AIDS Care ‐ Psychological and Socio‐Medical Aspects of AIDS/HIV 2016;28:33‐8.
Mfinanga S, Chanda D, Kivuyo SL, Guinness L, Bottomley C, Simms V, et al. Cryptococcal meningitis screening and community‐based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open‐label, randomised controlled trial. Lancet 2015;385(9983):2173‐82. [PUBMED: 25765698]
Lesotho Ministry of Health. National guidelines on the use of antiretroviral therapy for HIV prevention and treatment. www.aidsfree.usaid.gov/sites/default/files/lesotho_art_2016.pdf. Lesotho Ministry of Health, (accessed 25 January 2018).
Nachega JB, Parienti JJ, Uthman OA, Gross R, Dowdy DW, Sax PE, et al. Lower pill burden and once‐daily antiretroviral treatment regimens for HIV infection: a meta‐analysis of randomized controlled trials. Clinical Infectious Diseases 2014;58(9):1297‐307.
National AIDS and STI Control Programme. Guidelines on use of antiretroviral drugs for treating and preventing HIV infections in Kenya. www.faces‐kenya.org/wp‐content/uploads/2016/07/Guidelines‐on‐Use‐of‐Antiretroviral‐Drugs‐for‐Treating‐and‐Preventing‐HI....pdf. Nairobi: Ministry of Health, 2016.
National Centre for AIDS and STD Control. National anti‐retroviral therapy guidelines. www.who.int/hiv/pub/guidelines/nepal_art.pdf. Kathmandu: Ministry of Health and population, 2009.
National Department of Health South Africa. National consolidated guidelines for the prevention of mother‐to‐child transmission of HIV (PMTCT) and the management of HIV in children, adolescents and adults. aidsfree.usaid.gov/sites/default/files/tx_south‐africa_pmtct_2015.pdf. Pretoria: Department of Health, April 2015.
Okeke NL, Ostermann J, Thielman NM. Enhancing linkage and retention in HIV care: a review of interventions for highly resourced and resource‐poor settings. Current HIV/AIDS Reports 2014;11(4):376‐92.
Pellowski JA, Kalichman SC, White D, Amaral CM, Hoyt G, Kalichman MO. Real‐time medication adherence monitoring intervention: test of concept in people living with HIV infection. Journal of the Association of Nurses in AIDS Care 2014;25(6):646‐51.
Pilcher CD, Ospina‐Norvell C, Dasgupta A, Jones D, Hartogensis W, Torres S, et al. The effect of same‐day observed initiation of antiretroviral therapy on HIV viral load and treatment outcomes in a US public health setting. Journal of Acquired Immune Deficiency Syndromes 2017;74(1):44‐51.
Reddy EA, Agala CB, Maro VP, Ostermann J, Pence BW, Itemba DK, et al. Test site predicts HIV care linkage and antiretroviral therapy initiation: a prospective 3.5 year cohort study of HIV‐positive testers in northern Tanzania. BMC Infectious Diseases 2016;16:497.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub‐saharan Africa: a systematic review. PLoS Medicine 2011;8(7):e1001056.
Rosen S, Maskew M, Fox MP, Nyoni C, Mongwenyana C, Malete G, et al. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: the RapIT randomized controlled trial. PLoS Medicine 2016;13(5):e1002015.
Sollis KA, Smit PW, Fiscus S, Ford N, Vitoria M, Essajee S, et al. Systematic review of the performance of HIV viral load technologies on plasma samples. PLoS ONE 2014;9(2):e85869.
Swenson LC, Cobb B, Geretti AM, Harrigan PR, Poljak M, Seguin‐Devaux C, et al. Comparative performances of HIV‐1 RNA load assays at low viral load levels: results of an international collaboration. Journal of Clinical Microbiology 2014;52(2):517‐23.
Teklu AM, Delele K, Abraha M, Belayhun B, Gudina EK, Nega A. Exploratory analysis of time from HIV diagnosis to ART start, factors and effect on survival: a longitudinal follow up study at seven teaching hospitals in Ethiopia. Ethiopian Journal of Health Sciences 2017;27(Suppl 1):17‐28.
Joint United Nations Programme on HIV/AIDS. 90‐90‐90 ‐ an ambitious treatment target to help end the AIDS epidemic. www.unaids.org/en/resources/documents/2017/90‐90‐90. UNAIDS, (accessed 1 January 2017).
Joint United Nations Programme on HIV/AIDS. Global HIV statistics. www.unaids.org/en/resources/fact‐sheet. UNAIDS, (accessed 8 September 2017).
UNICEF. Options B and B+: key considerations for countries to implement and equity‐focused approach. www.unicef.org/aids/files/hiv_Key_considerations_options_B.pdfJuly 2012.
Uthman OA, Okwundu C, Gbenga K, Volmink J, Dowdy D, Zumla A, et al. Optimal timing of antiretroviral therapy initiation for hiv‐infected adults with newly diagnosed pulmonary tuberculosis: a systematic review and meta‐analysis. Annals of Internal Medicine 2015;163(1):32‐9.
Wachira J, Naanyu V, Genberg B, Koech B, Akinyi J, Kamene R, et al. Health facility barriers to HIV linkage and retention in Western Kenya. BMC Health Services Research 2014;14:646.
World Health Organization. Programmatic update. Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Executive summary. www.who.int/iris/bitstream/10665/70892/2/WHO_HIV_2012.6_eng.pdf. World Health Organization, April 2012.
World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Available at http://www.who.int/hiv/pub/arv/arv‐2016/en/. 2nd Edition. Geneva: WHO, June 2016.
World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. www.who.int/iris/bitstream/10665/255884/1/9789241550062‐eng.pdf?ua=1. World Health Organization, (accessed 18 July 2017).
World Health Organization. Number of deaths due to HIV/AIDS. Global Health Observatory (GHO) data. www.who.int/gho/hiv/en/ (accessed 18 July 2017).
Wilkinson L, Duvivier H, Patten G, Solomon S, Mdani L, Patel S, et al. Outcomes from the implementation of a counselling model supporting rapid antiretroviral treatment initiation in a primary healthcare clinic in Khayelitsha, South Africa. Southern African Journal of HIV Medicine 2015;16(1):7. [10.4102/sajhivmed.v16i1.367 ]
World Bank. World Bank country and lending groups. datahelpdesk.worldbank.org/knowledgebase/articles/906519‐world‐bank‐country‐and‐lending‐groups. World Bank Group, (accessed 4 July 2017).
Wynberg E, Cooke G, Shroufi A, Reid SD, Ford N. Impact of point‐of‐care CD4 testing on linkage to HIV care: a systematic review. Journal of the International AIDS Society 2014;17:18809.
Figuras y tablas -
Figure 1
Conceptual model of factors influencing the HIV care continuum. Abbreviations: PLWH: people living with HIV, ART: antiretroviral therapy, IRIS: immune reconstitution inflammatory syndrome
| Options | Treatment for pregnant women with CD4 count < 350 cells/mm³ | Prophylaxis for pregnant women with CD4 count > 350 cells/mm³ |
| Option A | ART started as soon as HIV is diagnosed, continued for life | Antivirals started as soon as 14 weeks of gestation and continued until 7 days post‐partum |
| Option B | ART started as soon as HIV is diagnosed, continued for life | Antivirals started as soon as 14 weeks of gestation until childbirth if not breastfeeding or until one week after cessation of breastfeeding |
| Option B+ | ART initiated as soon as HIV diagnosis and continued for life | |
| Source: WHO 2012. | ||
Figuras y tablas -
Table 1. Antiretroviral treatment and prophylaxis for pregnant women according to the WHO Prevention of mother‐to‐child transmission programmes
